chartexchange

IYH and XBI: Two Distinct Paths to Investing in Healthcare

The Motley Fool | Nov 7, 2026 12:15 PM EST

iShares U.S. Healthcare ETF (NYSEMKT:IYH) provides broad-based exposure across pharmaceuticals and medical equipment, whereas the State Street SPDR S&P Biotech ETF (NYSEMKT:XBI) focuses narrowly on the more volatile biotechnology segment. Investors choosing between these two funds are deciding between a total-sector approach and a sub-industry tilt. While both reside in the healthcare space, their risk profiles and underlying drivers differ significantly. One offers the stability of established cash flows, while the other tracks an equal-weighted index of companies often in the clinical trial phase. The iShares fund is slightly more expensive, with a 0.37% expense ratio compared to 0.35% for the SPDR fund. However, IYH offers a higher yield of 1.1%, representing a 0.75 percentage-point advantage over XBI. For long-term investors, this higher payout could provide a meaningful cushion during periods of sectorwide volatility, even though the annual management fees are nominally higher for the iShares product. Continue reading

Read original article